Stryker Dirección

Dirección controles de criterios 3/4

El CEO de Stryker's es Kevin Lobo , nombrado en Oct 2012, tiene una permanencia de 11.5 años. compensación anual total es $20.77M, compuesta por 6.7% salario y 93.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.026% de las acciones de la empresa, por valor de $33.92M. La antigüedad media del equipo directivo y de la junta directiva es de 5.6 años y 6.7 años, respectivamente.

Información clave

Kevin Lobo

Chief Executive Officer (CEO)

US$20.8m

Compensación total

Porcentaje del salario del CEO	6.7%
Permanencia del CEO	11.5yrs
Participación del CEO	0.03%
Permanencia media de la dirección	5.6yrs
Promedio de permanencia en la Junta Directiva	6.7yrs

Actualizaciones recientes de la dirección

Recent updates

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Aug 22

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Jul 18

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Jul 06

These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well

Jun 17

Stryker: Good Prospects

Jun 14

With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

May 24

Should You Think About Buying Stryker Corporation (NYSE:SYK) Now?

May 01

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Apr 18

Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Apr 06

Is Stryker (NYSE:SYK) Using Too Much Debt?

Feb 27

Stryker: Typically Excellent, Typically Expensive

Feb 16

Stryker Has A Slowing FCF Conversion And No Plans Of Share Buyback

Feb 07

If EPS Growth Is Important To You, Stryker (NYSE:SYK) Presents An Opportunity

Feb 02

Stryker Non-GAAP EPS of $3.00 beats by $0.16, revenue of $5.2B beats by $230M

Jan 31

Stryker initiated at sector weight by KeyBanc on limited upside potential

Jan 25

Stryker: Excellent Recent And Continuing Performance

Jan 09

Be Wary Of Stryker (NYSE:SYK) And Its Returns On Capital

Jan 08

At US$243, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?

Dec 26

Stryker's (NYSE:SYK) Upcoming Dividend Will Be Larger Than Last Year's

Dec 14

Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Dec 12

Stryker lifts dividend by 7.9% to $0.75/share

Dec 07

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Kevin Lobo en comparación con los beneficios de Stryker?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	US$21m	US$1m	US$3b
Sep 30 2023	n/a	n/a	US$3b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$3b
Dec 31 2022	US$19m	US$1m	US$2b
Sep 30 2022	n/a	n/a	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$2b
Dec 31 2021	US$16m	US$1m	US$2b
Sep 30 2021	n/a	n/a	US$2b
Jun 30 2021	n/a	n/a	US$2b
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	US$13m	US$1m	US$2b
Sep 30 2020	n/a	n/a	US$2b
Jun 30 2020	n/a	n/a	US$2b
Mar 31 2020	n/a	n/a	US$2b
Dec 31 2019	US$15m	US$1m	US$2b
Sep 30 2019	n/a	n/a	US$3b
Jun 30 2019	n/a	n/a	US$4b
Mar 31 2019	n/a	n/a	US$4b
Dec 31 2018	US$14m	US$1m	US$4b
Sep 30 2018	n/a	n/a	US$1b
Jun 30 2018	n/a	n/a	US$1b
Mar 31 2018	n/a	n/a	US$1b
Dec 31 2017	US$14m	US$1m	US$1b

Compensación vs. Mercado: La compensación total de Kevin($USD20.77M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD13.51M).

Compensación vs. Ingresos: La compensación de Kevin ha sido consistente con los resultados de la empresa en el último año.

CEO

Kevin Lobo (58 yo)

11.5yrs

Permanencia

US$20,767,847

Compensación

Mr. Kevin A. Lobo has been the Chief Executive Officer of Stryker Corporation since October 1, 2012 and serves as its President since October 01, 2021. He serves as Chairman of the Board at The Advanced Me...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kevin Lobo	Chairman	11.5yrs	US$20.77m	0.026% $ 33.8m
Glenn Boehnlein	VP & CFO	8yrs	US$6.84m	0.0068% $ 8.7m
Viju Menon	Group President of Global Quality & Operations	6yrs	US$4.47m	0.0024% $ 3.1m
J. Pierce	Group President of MedSurg & Neurotechnology	5.7yrs	US$6.49m	0.015% $ 19.3m
Spencer Stiles	Group President of Orthopaedics & Spine	5.7yrs	US$6.49m	0.014% $ 17.5m
William Berry	VP & Chief Accounting Officer	2.7yrs	sin datos	0.00069% $ 880.6k
Robert Cohen	CTO and VP of Global R&D - Joint Replacement	no data	sin datos	sin datos
Alan Douville	VP, Chief Information Officer & Chief Information Security Officer	5.6yrs	sin datos	sin datos
Jason Beach	Vice President of Finance & Investor Relations	1.8yrs	sin datos	sin datos
Robert Fletcher	VP & Chief Legal Officer	5yrs	US$2.24m	0.0025% $ 3.2m
Dana McMahon	VP & Chief Compliance Officer	no data	sin datos	sin datos
Yin Becker	VP of Communications	5.3yrs	sin datos	0.0083% $ 10.6m

5.6yrs

Permanencia media

56yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de SYK es experimentado (5.6 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kevin Lobo	Chairman	11.5yrs	US$20.77m	0.026% $ 33.8m
Lisa Skeete Tatum	Independent Director	3.9yrs	US$319.25k	0.00040% $ 510.5k
Howard Cox	Director Emeritus	5.9yrs	US$38.86k	sin datos
John Brown	Chairman Emeritus	no data	US$286.99k	5.27% $ 6.7b
Ronda Stryker	Independent Director	40.3yrs	US$322.74k	4.95% $ 6.3b
Mary Brainerd	Independent Director	6.7yrs	US$332.59k	0.0013% $ 1.7m
Srikant T. Datar	Independent Director	14.8yrs	US$319.25k	0.0084% $ 10.7m
Allan Golston	Independent Director	13.3yrs	US$334.25k	0.0031% $ 3.9m
Sherilyn S. McCoy	Lead Independent Director	5.9yrs	US$354.16k	0.00022% $ 280.8k
Rajeev Suri	Independent Director	5.9yrs	US$319.25k	0.0012% $ 1.5m
Giovanni Caforio	Independent Director	3.3yrs	US$319.25k	0.00040% $ 510.5k
Andrew Silvernail	Independent Director	10.4yrs	US$342.74k	0.0015% $ 1.9m

6.7yrs

Permanencia media

61.5yo

Promedio de edad

Junta con experiencia: La junta directiva de SYK se considera experimentada (6.7 años de antigüedad promedio).

Stryker Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

VP & Chief Accounting Officer notifies of intention to sell stock

Independent Director recently sold US$100m worth of stock

Independent Director notifies of intention to sell stock

VP & CFO exercised options and sold US$8.3m worth of stock

Insufficient new directors

Stryker Corporation, Annual General Meeting, May 09, 2024

Recent updates

Stryker: A Great Company At An Expensive Price

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

VP & Chief Accounting Officer notifies of intention to sell stock

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Fourth quarter dividend of US$0.80 announced

New minor risk - Insider selling

Independent Director recently sold US$100m worth of stock

Independent Director notifies of intention to sell stock

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

VP & CFO exercised options and sold US$8.3m worth of stock

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Insufficient new directors

Stryker: Mako Shoulder And Spine Launches Are On The Way

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of US$0.80 per share at 1.0% yield

Stryker Corporation (NYSE:SYK) executed a binding offer to acquire Serf from SAS Menix.

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Stryker Corporation, Annual General Meeting, May 09, 2024

Stryker Corporation Announces Dr. Srikant Datar Will Retire from Board of Directors

Stryker Corporation Declares Quarterly Dividend, Payable on January 31, 2024

VP & CFO exercised options and sold US$1.6m worth of stock

Why Stryker Is An Awesome Healthcare Compounder

Chairman notifies of intention to sell stock

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Stryker Corporation Provides Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS misses analyst expectations

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Stryker: Don't Buy This Dividend Champion (Yet)

Stryker to Showcase Q Guidance System with Spine Guidance Software

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Stryker Corporation to Report Q3, 2023 Results on Nov 02, 2023

Is Stryker (NYSE:SYK) A Risky Investment?

Upcoming dividend of US$0.75 per share at 1.0% yield

Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

Stryker Corporation Releases Its Next-Generation of Advanced Surgical Cameras

Stryker’S Pangea Systems Receive Food & Drug Administration Clearance

Key Executive recently sold US$1.4m worth of stock

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Stryker Corporation Provides Earnings Guidance for the Year 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Stryker Corporation to Report Q2, 2023 Results on Aug 03, 2023

Upcoming dividend of US$0.75 per share at 1.0% yield

These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well

Stryker: Good Prospects

Independent Director recently sold US$139k worth of stock

Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software

With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

Independent Director recently sold US$286k worth of stock

Independent Director notifies of intention to sell stock

Price target increased by 7.5% to US$310

Stryker Corporation Declares Quarter Dividend, Payable on July 31, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Should You Think About Buying Stryker Corporation (NYSE:SYK) Now?

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Chairman exercised options and sold US$140k worth of stock